Rule 35. (1) An individual who is applying for or renewing a controlled substance license or who is
licensed to prescribe or dispense controlled substances pursuant tounder section 7303 of the code, MCL
333.7303, shall complete a 1-time training in opioids and controlled substances awareness before
applying for the license or renewal. The training must meet that meets the following standards:
(a) Training content must cover allboth of the following topics:
(i) Use of opioids and other controlled substances.
(ii) Integration of treatments.
(iii) Alternative treatments for pain management.
(iv) Counseling on the effects and risks associated with using opioids and other controlled substances.
(v) The stigma of addiction.
(vi) Utilizing the MAPS.
(vii) (ii) State and federal laws regarding prescribing and dispensing controlled substances.
(viii) Security features for opioids and other controlled substances and prescriptions, and proper
disposal requirements for opioids and other controlled substances.
(b) Topics covered under subrule (1)(a) of this rule may be obtained from more than 1 program.
(c) Acceptable providers or methods of training include any of the following:
(i) Training offered by a nationally recognized or state-recognized health-related organization.
(ii) Training offered by, or in conjunction with, a state or federal agency.
(iii) Training offered by a continuing education program or activity that is accepted by a licensing
board established under article 15 of the code, MCL 333.16101 to 333.18838.
(iv) Training obtained in an educational program that has been approved by a board established
under article 15 of the code, MCL 333.16101 to 333.18838, for initial licensure or registration, or by a
college or university.
(d) Acceptable modalities of training include any of the following:
(i) Teleconference or webinar.
(ii) Online presentation.
(iii) Live presentation.
(iv) Printed or electronic media.
(2) A prescriber or dispenser shallmay not delegate, allow by a practice agreement, or order the
prescribing, or dispensing of a controlled substance as allowed by the code to an individual, other than a
physician’s assistant, only after the individual has complied with subrules subrule (1) and (5) of this rule.
A physician’s assistant is subject to subrules (1), (3), and (4) of this rule.
(3) The department may select and audit licensees and request documentation of proof of completion
of training. A licensee shall maintain proof of completion of training for 3 renewal periods plus 1
additional year. If audited, an individual shall provide an acceptable proof of completion of training,
including either1 of the following:
(a) A completion certificate issued by the training provider that includes the date, provider name,
name of training, and individual’s name.
(b) A self-attestation by the individual that includes the date, provider name, name of training, and
individual’s name.
(4) An individual who has been issued a controlled substance license pursuant tounder section 7303 of
the code, MCL 333.7303, shall complete the controlled substance training required by subrule (1) of this
rule as follows:
(a) A licensee who is renewing his or hera controlled substance license shall complete the controlled
substance training by the end of the first renewal cycle that begins after January 4, 2019.
(b) Other than a license renewal under subdivision (a) of this subrule, beginning September 1, 2019,
the department shall not issue a controlled substance license until an applicant provides proof of having
completed the controlled substance training.